{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:44:48Z","timestamp":1779345888333,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.seizure.2021.06.027","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T04:26:53Z","timestamp":1624940813000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: A population-based study on German health insurance data"],"prefix":"10.1016","volume":"91","author":[{"given":"Adam","family":"Strzelczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann Philipp","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Schubert-Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.06.027_bib0001","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","article-title":"Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations","volume":"16","author":"Curatolo","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"The Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0003","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pediatrneurol.2018.10.011","article-title":"The impact of psychiatric symptoms on tuberous sclerosis complex and utilization of mental health treatment","volume":"91","author":"Mowrey","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/epi.13467","article-title":"Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex","volume":"57","author":"Jeong","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2021.06.027_bib0007","unstructured":"Novartis Pharmaceuticals Corporation. Afinitor\u00ae (everolimus) tablets, for oral use; Afinitor disperz\u00ae (everolimus tablets for oral suspension): highlights of prescribing information 2018. https:\/\/www.pharma.us.novartis.com\/sites\/www.pharma.us.novartis.com\/files\/afinitor.pdf (accessed July 8, 2018)."},{"key":"10.1016\/j.seizure.2021.06.027_bib0008","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2021.06.027_bib0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/13696998.2018.1487447","article-title":"Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families","volume":"21","author":"Skalicky","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.seizure.2021.06.027_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13023-019-1258-3","article-title":"A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)","volume":"15","author":"Z\u00f6llner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2021.06.027_bib0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yebeh.2019.01.045","article-title":"The direct cost of seizure events in severe childhood-onset epilepsies: a retrospective claims-based analysis","volume":"93","author":"Reaven","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.06.027_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015236","article-title":"Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)","volume":"7","author":"Shepherd","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.seizure.2021.06.027_bib0014","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0883073812448437","article-title":"Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study","volume":"28","author":"Lennert","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","article-title":"Epilepsy in tuberous sclerosis patients in Sweden - Healthcare utilization, treatment, morbidity, and mortality using national register data","volume":"53","author":"Welin","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.06.027_bib0016","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2018.06.011","article-title":"Epilepsy treatment patterns among patients with tuberous sclerosis complex","volume":"391","author":"Song","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2021.06.027_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2016.07.001","article-title":"Guideline conform initial monotherapy increases in patients with focal epilepsy: a population-based study on German health insurance data","volume":"41","author":"Ertl","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.06.027_bib0018","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/epi.13837","article-title":"Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0019","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/epi.14729","article-title":"Burden and epidemiology of status epilepticus in infants, children, and adolescents: a population-based study on German health insurance data","volume":"60","author":"Schubert-Bast","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107647","article-title":"Epidemiology, healthcare resource use, and mortality in patients with probable Lennox-Gastaut syndrome: a population-based study on German health insurance data","volume":"115","author":"Strzelczyk","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.06.027_bib0021","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2021.06.027_bib0022","unstructured":"Destatis. German Health Consumer Price Index 2020. https:\/\/www.destatis.de\/EN\/Themes\/Economy\/Prices\/Consumer-Price-Index\/_node.html (accessed May 18, 2020)."},{"key":"10.1016\/j.seizure.2021.06.027_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Acad Sci"},{"key":"10.1016\/j.seizure.2021.06.027_bib0024","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2021.06.027_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1515\/tnsci-2018-0023","article-title":"Tuberous sclerosis complex: clinical spectrum and epilepsy: a retrospective chart review study","volume":"9","author":"Almobarak","year":"2018","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.seizure.2021.06.027_bib0026","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.seizure.2021.06.027_bib0027","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0012162206001058","article-title":"Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland","volume":"48","author":"Devlin","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0028","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/epi.12430","article-title":"Epilepsy in TSC: certain etiology does not mean certain prognosis","volume":"54","author":"Vignoli","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0029","doi-asserted-by":"crossref","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","article-title":"Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients","volume":"8","author":"Wataya-Kaneda","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.seizure.2021.06.027_bib0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40263-018-0544-2","article-title":"Use of emergency medication in adult patients with epilepsy: a multicentre cohort study from Germany","volume":"32","author":"Kadel","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2021.06.027_bib0031","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13696998.2016.1199432","article-title":"The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the Clinical Practice Research Datalink","volume":"19","author":"Kingswood","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.seizure.2021.06.027_bib0032","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13023-021-01838-w","article-title":"Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature","volume":"16","author":"Z\u00f6llner","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2021.06.027_bib0033","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yebeh.2018.03.006","article-title":"Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers","volume":"82","author":"Hamer","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.06.027_bib0034","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/epi.16829","article-title":"Everolimus in adult tuberous sclerosis complex patients with epilepsy: too late for success? A retrospective study","volume":"62","author":"Stockinger","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.06.027_bib0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejpn.2018.05.006","article-title":"Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations","volume":"22","author":"Curatolo","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0036","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17512433.2021.1911643","article-title":"Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature","volume":"14","author":"Strzelczyk","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0038","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-0035-1552616","article-title":"Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments","volume":"35","author":"Saxena","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0039","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.seizure.2015.02.031","article-title":"Injuries from seizures are a serious, persistent problem in childhood onset epilepsy: a population-based study","volume":"27","author":"Camfield","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.06.027_bib0040","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fneur.2017.00712","article-title":"The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using German health insurance data","volume":"8","author":"Strzelczyk","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0041","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.seizure.2021.06.027_bib0042","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","article-title":"The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)","volume":"20","author":"Kingswood","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.06.027_bib0043","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:01:53Z","timestamp":1761012113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S1059131121002144"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.06.027","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: A population-based study on German health insurance data","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}